Published in

Taylor and Francis Group, Expert Opinion on Pharmacotherapy, 3(18), p. 325-326, 2017

DOI: 10.1080/14656566.2017.1282697

Links

Tools

Export citation

Search in Google Scholar

Upfront nilotinib therapy among patients with chronic myeloid leukemia in chronic phase

Journal article published in 2017 by Ahmet Emre Eskazan ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO